期刊文献+

以难治性单系血细胞减少为早期表现的骨髓增生异常综合征——附13例报道 被引量:6

Myelodysplastic Syndrome with Early Presentation of Refractory Monolineage Cytopenia----with Report of 13 Cases
下载PDF
导出
摘要 为揭示难治性单系血细胞减少与骨髓增生异常综合征(MDS)之间关系,对13例以难治性单系血细胞减少为早期表现的MDS进行了回顾性分析。结果如下:(1)10年中以顽固性单系血细胞减少为早期表现的MDS患者共13例,占我院确诊219例MDS患者的5.9%,其中粒细胞减少者4例,红细胞减少者4例,血小板减少者5例。(2)患者从出现单系血细胞减少至确诊为MDS的平均时间为(48.5±55.3)月,其中粒细胞减少、红细胞减少和血小板减少的平均时间分别为(12.5±9.5)月,(53.8±54.6)月和(59.2±65.5)月。(3)13例患者有以下特点:①大红细胞增多,骨髓中红系中、晚幼红细胞比例升高;②偶有一过性个别细胞病态造血表现;③红细胞减少和血小板减少者均转为RA和RAS亚型,而粒细胞减少者大多转为RAEB;④部分患者有自身抗体。结论:部分难治性单系血细胞减少实质上为一种早期MDS的表现。 To find the relationship between myelodysplastic syndrome ( MDS) and refractory monolineage cytopenia,thirteen cases of MDS with early presentation of monolineage refractory cytopenia were analyzed retrospectively.The results were as follows: (l)The percentage of 13 cases with refractory monolineage cytopenia were 5.9% of the total 219 MDS patients in the past 10 years.(2)The median time of patients with monlineage cytopenia to MDS diagnosed was (48.5 + 55.3) months.The median times from monolineage cytopenia to MDS diagnosed for patients with neutropenia,erythrocytopenia and thrombocytopenia were (12.5+9.5) months,(53.8+54.6) months and (59.2 + 65.5 ) months,respectively.(3)The common characteristics of 13 cases were as follows: (a) the macrocytic erythrocytes in peripheral blood and the percentage of intermediate and late erythroblast in bone marrow were increased; (b) occasionally few cells with dysplasia could be found; (c) all patients with erythrocytopenia and thrombocytopenia transformed to RA and RAS while the most of patients with neutropenia transformed to RAEB subtype; (d) autoantibody could be found in part of the patients.It is concluded that some of refractory monolineage cytopenias in essence are the early states of MDS.
机构地区 中国医学科学院
出处 《中国实验血液学杂志》 CAS CSCD 2002年第4期303-306,共4页 Journal of Experimental Hematology
关键词 骨髓增生异常综合征 难治性单系血细胞减少 MDS 诊断 临床特征 早期表现 myelodysplastic syndrome refractory monolineage cytopenia cytopenia
  • 相关文献

参考文献7

  • 1Rosati S, Mick R, Xu F, et al. Refractory cytopenia with multilineage displasia: further characterization of an "unclassifiable"myelodysplastic syndrome. Leukemia, 1996; 10:20 - 26
  • 2Menke DM, Colon-Otero G, Cockerill KJ, et al. Refractory throm bocytopenia, A myelodysplastic syndrome that may mimic immune thrombocytopenia purpura. Am J Clin Pathal, 1992; 98:502 - 510
  • 3Dale DC. Hematopoietic growth factors for the treatment of severe chronic neutropenia. Stem cells, 1995; 13:94- 100
  • 4Welte K, Boxer LA. Severe chronic neutropenia: pathophysiology and therapy. Semin Hematol, 1991; 34:267- 278
  • 5Anttila P, Ihalainen J, Salo A, et al. Idiopathic macrocytic anemia in the aged: molecular and cytogenetic findings. Br J Haematol, 1995; 90:797 - 803
  • 6Irvine AE, Magill MK, Somerville LE, et al. Spontaneous in tramedullary apoptosis is present in disorders other than myelodys plasia. Exp Hematol, 1998; 26:435 - 439
  • 7陈书长,吕照江,朱红,扬经敏,张之南.axl基因在骨髓增生异常综合征患者外周血细胞的表达[J].中国实验血液学杂志,1998,6(1):63-65. 被引量:2

共引文献1

同被引文献48

  • 1吴雨洁,李建勇,仇海荣,肖冰,张建富,宋君红.四色流式细胞术分析骨髓增生异常综合征原始细胞免疫表型[J].中国实验血液学杂志,2006,14(1):50-53. 被引量:14
  • 2王涓冬,潘祥林,尹哲,孙俊华,孔桂香,陈颖洁,姜翠英,窦爱霞,王志仑.血小板糖蛋白特异性抗体在骨髓增生异常综合征患者中的表达及其意义[J].中国实验血液学杂志,2007,15(1):95-98. 被引量:6
  • 3Cachia P G, Taylor C, Thompson P W. Nondysplastic myelodysplasia [J]. Leukemia,1994, 8(4):677-681.
  • 4Anttila P, Ihalainen J, Salo A, et al. Idiopathic macrocytic anaemia in the aged:molecular and cytogenetic findings [J]. Br J Haematol, 1995, 90(4):797-803.
  • 5Steensma D P, Dewald G W, Hodnefield J M,et al. Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia[J]. Leuk Res,2003, 27(3):235 -242.
  • 6Bain B J. The bone marrow aspirate of healthy subjects[J]. Br J Haematol, 1996, 94(1):206-209.
  • 7Ramos F, Fernandez-Ferro S, Suarez D, et al.myelodysplastic syndrome: a search for minimal diagnostic criteria[J]. Leuk Res, 1999, 23(3):283 -290.
  • 8Hasle H, Niemeyer C M, Chessells J M, et al.A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases[J]. Leukemia, 2003, 17(2):277-282.
  • 9Tuzuner N, Cox C, RoweJ M, et al. Hypocellular myelodysplastic syndromes (MDS): newproposals[J]. Br J Haematol, 1995,91(3):612-617.
  • 10Tuzuner N, Cox C, Rowe J M, et al. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction[J]. Leuk Res,1994, 18(8):559-564.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部